Our studies in vivo and in vitro showed that GnRH and GnRH III, as ligands of GnRH-R, could recognize the receptor expressed on H1299 cells and then delivered p53 fusion proteins into tumor cells and then exerted their targeted antitumor functions with limited side effects. This evidence concerns the gene GNRHR and neoplasm.